PURPLE BIOTECH LTD.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.4M | $70.2M | $10.9M |
| FY2022 | $7.7M | $54.6M | $15.0M |
| FY2023 | $10.1M | $44.3M | $14.5M |
| FY2024 | $4.2M | $37.0M | $7.4M |
| FY2025 | $7.9M | $17.6M | $8.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.4M | $70.2M | $10.9M |
| FY2022 | $7.7M | $54.6M | $15.0M |
| FY2023 | $10.1M | $44.3M | $14.5M |
| FY2024 | $4.2M | $37.0M | $7.4M |
| FY2025 | $7.9M | $17.6M | $8.7M |